Business Context and Reporting Period
Company: Universe Pharmaceuticals INC (Cayman Islands exempted company)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2023 (Specifically regarding events on August 14, 2023)
Subject: Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory compliance notification and does not contain financial statements.
Material Changes
Regulatory Status Change: The Company has regained compliance with Nasdaq Rule 5450(a)(1) (the "Bid Price Rule").
- Previous Status: Received a deficiency letter on March 2, 2023, for failing to maintain a closing bid price of at least $1.00 per share for 30 consecutive business days.
- Compliance Period: Granted an initial 180-day period to regain compliance, expiring August 29, 2023.
- Current Status: On August 14, 2023, Nasdaq confirmed the Company evidenced a closing bid price of at or above $1.00 per share for 12 consecutive business days (July 28, 2023, through August 11, 2023).
- Outcome: The matter is now closed.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the resolution of the listing deficiency without providing forward-looking financial guidance or operational outlook.
Risks and Contingencies: The primary risk addressed was potential delisting due to non-compliance with the minimum bid price requirement. This risk has been mitigated as of the filing date.
Unusual Items: None reported beyond the resolution of the Nasdaq deficiency notice.
Investor Verification Checklist
- Verify the current trading price of Universe Pharmaceuticals INC ordinary shares to ensure continued compliance with the $1.00 minimum bid price.
- Confirm the Company's ongoing listing status on the Nasdaq Stock Market.
- Review subsequent filings for any new regulatory notices or financial performance updates, as this filing contains no financial data.